Literature DB >> 23334857

Abnormalities in carbohydrate and lipid metabolisms in high-fructose dietfed insulin-resistant rats: amelioration by Catharanthus roseus treatments.

Karuna Rasineni1, Ramesh Bellamkonda, Sreenivasa Reddy Singareddy, Saralakumari Desireddy.   

Abstract

High intake of dietary fructose has been shown to exert a number of adverse metabolic effects in humans and experimental animals. The present study was proposed to elucidate the effect of Catharanthus roseus (C. roseus) leaf powder treatment on alterations in carbohydrate and lipid metabolisms in rats fed with high-fructose diet. Male Wistar rats of body weight around 180 g were divided into four groups, two of these groups (groups C and C+CR) were fed with standard pellet diet and the other two groups (groups F and F+CR) were fed with high-fructose (66 %) diet. C. roseus leaf powder suspension in water (100 mg/kg body weight/day) was administered orally to group C+CR and group F+CR. At the end of a 60-day experimental period, biochemical parameters related to carbohydrate and lipid metabolisms were assayed. C. roseus treatment completely prevented the fructose-induced increased body weight, hyperglycemia, and hypertriglyceridemia. Hyperinsulinemia and insulin resistance observed in group F was significantly decreased with C. roseus treatment in group F+CR. The alterations observed in the activities of enzymes of carbohydrate and lipid metabolisms and contents of hepatic tissue lipids in group F rats were significantly restored to near normal values by C. roseus treatment in group F+CR. In conclusion, our study demonstrates that C. roseus treatment is effective in preventing fructose-induced insulin resistance and hypertriglyceridemia while attenuating the fructose-induced alterations in carbohydrate and lipid metabolisms. This study suggests that the plant can be used as an adjuvant for the prevention and/or management of insulin resistance and disorders related to it.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23334857     DOI: 10.1007/s13105-013-0233-z

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  49 in total

Review 1.  Insights into insulin resistance and type 2 diabetes from knockout mouse models.

Authors:  T Kadowaki
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  The determination of glycogen in liver and muscle by use of anthrone reagent.

Authors:  N V CARROLL; R W LONGLEY; J H ROE
Journal:  J Biol Chem       Date:  1956-06       Impact factor: 5.157

3.  Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women.

Authors:  Karen L Teff; Sharon S Elliott; Matthias Tschöp; Timothy J Kieffer; Daniel Rader; Mark Heiman; Raymond R Townsend; Nancy L Keim; David D'Alessio; Peter J Havel
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

Review 4.  Obesity and the metabolic syndrome in developing countries.

Authors:  Anoop Misra; Lokesh Khurana
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

5.  Taurine modifies insulin signaling enzymes in the fructose-fed insulin resistant rats.

Authors:  A T Anitha Nandhini; V Thirunavukkarasu; C V Anuradha
Journal:  Diabetes Metab       Date:  2005-09       Impact factor: 6.041

6.  Effects of insulin and dexamethasone on lipoprotein lipase in human adipose tissue.

Authors:  B Appel; S K Fried
Journal:  Am J Physiol       Date:  1992-05

Review 7.  Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years.

Authors:  P J Randle
Journal:  Diabetes Metab Rev       Date:  1998-12

Review 8.  Is the fructose index more relevant with regards to cardiovascular disease than the glycemic index?

Authors:  Mark S Segal; Elizabeth Gollub; Richard J Johnson
Journal:  Eur J Nutr       Date:  2007-09-01       Impact factor: 5.614

Review 9.  Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.

Authors:  Richard J Johnson; Mark S Segal; Yuri Sautin; Takahiko Nakagawa; Daniel I Feig; Duk-Hee Kang; Michael S Gersch; Steven Benner; Laura G Sánchez-Lozada
Journal:  Am J Clin Nutr       Date:  2007-10       Impact factor: 7.045

10.  Antihyperglycemic activity of Catharanthus roseus leaf powder in streptozotocin-induced diabetic rats.

Authors:  Karuna Rasineni; Ramesh Bellamkonda; Sreenivasa Reddy Singareddy; Saralakumari Desireddy
Journal:  Pharmacognosy Res       Date:  2010-05
View more
  1 in total

1.  Study the effect of s-methyl L-cysteine on lipid metabolism in an experimental model of diet induced obesity.

Authors:  Senthilkumar G P; Sithara Thomas; Sivaraman K; P Sankar; Zachariah Bobby
Journal:  J Clin Diagn Res       Date:  2013-11-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.